Inactivation of the Tumor Suppressor Genes Causing the Hereditary Syndromes Predisposing to Head and Neck Cancer via Promoter Hypermethylation in Sporadic Head and Neck Cancers

No abstract is available for this paper.

• Publication year

  2010

• Venue

  ORL

• Publication date

  2010-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000292104PMID 20332657PMCID PMC2881891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dyskeratosis Congenita.

  2019cited by this paper
• Dyskeratosis congenita bei einem 40-jährigen Patienten

  2006cited by this paper
• [Dyskeratosis congenita in a 40-year-old patient].

  2006cited by this paper
• Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation.

  2006cited by this paper
• Promoter methylation and inactivation of tumour-suppressor genes in oral squamous-cell carcinoma.

  2006cited by this paper
• Genome‐Wide Profiling of Oral Squamous Cell Carcinoma by Array‐Based Comparative Genomic Hybridization

  2006cited by this paper
• Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita

  2006cited by this paper
• Dyskeratosis Congenita: A Disorder of Defective Telomere Maintenance?

  2005cited by this paper
• Head and neck squamous cell carcinoma in patients with Fanconi anemia.

  2005cited by this paper
• Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism.

  2005cited by this paper
• Molecular pathogenesis of Fanconi anemia.

  2005cited by this paper
• Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.

  2004cited by this paper
• Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

  2004cited by this paper
• Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature.

  2004cited by this paper
• Molecular pathology of head‐and‐neck cancer

  2004cited by this paper
• Genetic basis of Fanconi anemia

  2003cited by this paper
• The Fanconi Anemia/BRCA Signaling Pathway: Disruption in Cisplatin-Sensitive Ovarian Cancers

  2003cited by this paper
• Cancer incidence in persons with Fanconi anemia.

  2003cited by this paper
• Genetic basis of Fanconi anemia.

  2003cited by this paper
• The Fanconi road to cancer.

  2003cited by this paper
• Cancer in Fanconi anemia, 1927–2001

  2003cited by this paper
• Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.

  2003influential reference
• Epigenetic inactivation of RASSF1A in head and neck cancer.

  2003cited by this paper
• Molecular Pathogenesis of Fanconi Anemia

  2002cited by this paper
• BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma

  2002cited by this paper
• The Role of DNA Methylation in Mammalian Epigenetics

  2001cited by this paper
• The emerging genetic and molecular basis of Fanconi anaemia

  2001cited by this paper
• Oral carcinoma in a young man: a case of dyskeratosis congenita

  2000cited by this paper
• Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.

  2000cited by this paper
• Dyskeratosis congenita in all its forms

  2000cited by this paper
• Tongue cancer as a complication of dyskeratosis congenita in a woman.

  1999cited by this paper
• Dyskeratosis Congenita (DC) Registry: identification of new features of DC

  1998cited by this paper
• Poster 7: A Genetic Progression Model for Head and Neck Cancer: Implications for Field Cancerization

  1996cited by this paper
• High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996influential reference
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• Oral squamous cell carcinoma in a case of dyskeratosis congenita.

  1994cited by this paper
• Dyskeratosis congenita with macular cutaneous amyloid deposits.

  1984cited by this paper
• Multiple squamous‐cell carcinomas in fanconi's anemia

  1982cited by this paper
• Dyskeratosis congenita: clinical features and genetic aspects. Report of a family and review of the literature.

  1975cited by this paper
• Dyskeratosis congenita with associated periodontal disease.

  1974cited by this paper
• Dyskeratosis congenita.

  1971cited by this paper
• Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

  1969cited by this paper
• THE ASSOCIATION OF DYSKERATOSIS CONGENITA AND FANCONI'S ANAEMIA.

  1965cited by this paper
• Dyskeratosis congenita with pigmentation, dystrophia unguium, and leukoplakia oris; a follow-up report of two brothers.

  1958cited by this paper
• Dyskeratosis Congenita with Pigmentation, Dystrophia Unguium, and Leucokeratosis Oris: Review of the Known Cases Reported to Date and Discussion of the Disease from Various Aspects

  1955cited by this paper
• Dyskeratosis congenita with pigmentation, dystrophia unguium, and leucokeratosis oris; review of the known cases reported to date and discussion of the disease from various aspects.

  1955cited by this paper
• A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum.

  1951cited by this paper

• Head and Neck Cancer in Fanconi Anemia: Clinical Challenges and Molecular Insights into a DNA Repair Disorder

  2025cites this paper
• In silico studies of molecular alterations in fanconi anemia genes from cancer cell lines and samples

  2023cites this paper
• Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels

  2020cites this paper
• Gene Selection for the Discrimination of Colorectal Cancer.

  2019cites this paper
• Comprehensive review of genetic factors contributing to head and neck squamous cell carcinoma development in low‐risk, nontraditional patients

  2018cites this paper
• DNA Methylation of Telomere-Related Genes and Cancer Risk

  2018cites this paper
• Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients

  2018cites this paper
• Prediction of DNA methylation in the promoter of gene suppressor tumor.

  2018cites this paper
• Mutational and Functional Analysis of FANCB as a Candidate Gene for Sporadic Head and Neck Squamous Cell Carcinomas.

  2018cites this paper
• Salivary lactate dehydrogenase (LDH) as a tool for early diagnosis of oral cancer in individuals with Fanconi anemia.

  2018cites this paper
• Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

  2018cites this paper
• HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.

  2017cites this paper
• Birc2-Amplifikationen bei Plattenepithelkarzinomen des Kopf-Hals-Bereiches und deren Einfluss auf den Tumorphänotyp und die Patientenprognose

  2015cites this paper
• Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling

  2015cites this paper
• Next-generation sequencing technology in prostate cancer diagnosis, prognosis, and personalized treatment.

  2015cites this paper
• RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).

  2014cites this paper
• Methylation of SFRPs and APC genes in ovarian cancer infected with high risk human papillomavirus.

  2014cites this paper
• Oncology and Biophysics: A Need for Integration

  2014cites this paper
• DNA Methylierung ausgewählter BRCA- und Fanconi Anämie-Gene beim familiären Mammakarzinom

  2014cites this paper
• Implications of Systemic Dysfunction for the Etiology of Malignancy

  2013cites this paper
• Ion Gradients in Tissue and Organ Biology

  2013cites this paper
• Genome Stability Pathways in Head and Neck Cancers

  2013cites this paper
• Identification of Tumor Cell- and Stroma Derived Biomarkers of Treatment Response in Head and Neck Cancer

  2013cites this paper
• Biomarkers of HPV in head and neck squamous cell carcinoma.

  2012cites this paper
• Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma

  2012cites this paper
• Predicting recurrence after radiotherapy in head and neck cancer.

  2012cites this paper
• DNA Repair Capacity and the Risk of Head and Neck Cancer

  2012cites this paper
• Issues in Omics Data Integration for Gene Set Analysis and Aberrant Pathway Identification

  2012cites this paper
• DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract

  2012cites this paper
• Pyrosequencing-based DNA methylation profiling of Fanconi anemia/BRCA pathway genes in laryngeal squamous cell carcinoma.

  2011cites this paper
• Role of DNA methylation in head and neck cancer

  2011cites this paper
• Fanconi anaemia: from a monogenic disease to sporadic cancer

  2011cites this paper
• Fanconi Anemia/Brca Pathway and Head and Neck Squamous Cell Carcinomas

  2011cites this paper
• Fanconi Anemia Signaling and Biological Information Flow

  year unknowncites this paper